Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder
Version 2 2024-06-04, 01:07Version 2 2024-06-04, 01:07
Version 1 2022-10-19, 04:29Version 1 2022-10-19, 04:29
journal contribution
posted on 2024-06-04, 01:07 authored by Seetal DoddSeetal Dodd, Adam Walker, AJM Brnabic, N Hong, A Burns, Michael BerkMichael BerkIncidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder
History
Journal
BIPOLAR DISORDERSVolume
21Pagination
142-142Location
Sydney, AUSTRALIAStart date
2019-03-20End date
2019-03-23ISSN
1398-5647eISSN
1399-5618Language
EnglishPublication classification
E3.1 Extract of paperPublisher
WILEYUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC